Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Cattran

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of the American Society of Nephrology : JASN|July 20, 2007
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36Andrew D Paterson, Xiao-Qing Liu, Kairong Wang, et al.
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|May 15, 2020
Proteomic Analysis of Complement Proteins in Membranous NephropathyAishwarya Ravindran, Benjamin Madden, M Cristine Charlesworth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2008
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study GroupMelanie S Joy, Debbie S Gipson, Mary Dike, et al.
Journal of the American Society of Nephrology : JASN|February 8, 2008
IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathyXiao-Qing Liu, Andrew D Paterson, Ning He, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2025
Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA NephropathySufang Shi, Ian S D Roberts, Zixuan Wang, et al.
American Journal of Physiology. Renal Physiology|April 7, 2017
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Kidney Medicine|April 14, 2021
Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic VariantsCole Shulman, Emerald Liang, Misato Kamura, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study groupMelanie S Joy, Debbie S Gipson, Leslie Powell, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|July 20, 2007
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36Andrew D Paterson, Xiao-Qing Liu, Kairong Wang, et al.
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|May 15, 2020
Proteomic Analysis of Complement Proteins in Membranous NephropathyAishwarya Ravindran, Benjamin Madden, M Cristine Charlesworth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2008
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study GroupMelanie S Joy, Debbie S Gipson, Mary Dike, et al.
Journal of the American Society of Nephrology : JASN|February 8, 2008
IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathyXiao-Qing Liu, Andrew D Paterson, Ning He, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2025
Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA NephropathySufang Shi, Ian S D Roberts, Zixuan Wang, et al.
American Journal of Physiology. Renal Physiology|April 7, 2017
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Kidney Medicine|April 14, 2021
Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic VariantsCole Shulman, Emerald Liang, Misato Kamura, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study groupMelanie S Joy, Debbie S Gipson, Leslie Powell, et al.
Pageof 6